Evidence map›Paper›PMID 41144548›Full record

ArticlePLoS pathogens2025

The adenovirus E4orf1 protein initiates a feedback loop involving insulin and growth factor receptors, AKT, and NF-κB, leading to abnormal DNA content in infected cells.

Madison Moore, Jiang Kong, Ahlam Akmel, Michael A Thomas

Abstract read
In one paragraph

Article in PLoS pathogens, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Madison MooreDepartment of Biology, College of Arts and Sciences, Howard University, Washington, D.C., United States of America.
Jiang KongDepartment of Microbiology, School of Medicine, Howard University, Washington, D.C., United States of America.
Ahlam AkmelDepartment of Biology, College of Arts and Sciences, Howard University, Washington, D.C., United States of America.
Michael A ThomasDepartment of Biology, College of Arts and Sciences, Howard University, Washington, D.C., United States of America.ORCID 0000-0003-0134-8765

Funding

Effective Replicating Adenovirus-HIV VaccinesR00AI114379 · NIAID · HOWARD UNIVERSITY · PI THOMAS, MICHAEL A · 2016 to 2017
$498k
NIAID NIH HHS R00 AI114379
6 · The paper itself

Abstract

Abnormal DNA levels, such as aneuploidy and polyploidy, can indicate cellular transformation and cancer; however, the mechanisms remain poorly understood. All tumor viruses inherently cause abnormal DNA content in cells due to their oncogenes. During infections, adenovirus (Ad) oncogenes-early region 1A (E1A), early region 4 open reading frame 3 (E4orf3), and E4 open reading frame 1 (E4orf1)-promote the abnormal buildup of cellular DNA. Previous studies have described how E1A and E4orf3 lead infected cells to accumulate abnormal DNA content; however, the role of E4orf1 remains speculative. In this study, we generated cells that express E4orf1 to investigate its role in abnormal DNA content. The E4orf1-expressing cells initially exhibited no increase in DNA content compared to the control group. However, after Ad infection, they displayed higher ploidy levels. To detail how E4orf1 influences ploidy levels in Ad-infected cells, we employed pharmacological agents that target E4orf1 signaling. Our results indicate that E4orf1 enhances signaling from insulin and growth factor receptors to AKT and NF-κB, creating a feedback loop that elevates levels of cellular DNA in Ad-infected cells.

Indexed as

Adenoviridae InfectionsAdenovirus E4 ProteinsNF-kappa BProto-Oncogene Proteins c-aktAdenoviridaeFeedback, PhysiologicalHumansSignal TransductionAdenovirus E4 ProteinsNF-kappa BProto-Oncogene Proteins c-akt

Identifiers

PMID41144548
PMCPMC12578350

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.